Bluefin Capital Management, LLC Pfizer Inc Put Options Transaction History

Bluefin Capital Management, LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $617,016 - $753,222	14,100 New	14,100 $99,000
Q1 2022 May 16, 2022	SELL	$45.75 - $56.69 $13.6 Million - $16.9 Million	-297,800 Reduced 95.33%	14,600 $7,000
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $7.84 Million - $11.6 Million	189,700 Added 154.6%	312,400 $39,000
Q3 2021 Nov 15, 2021	BUY	$39.25 - $50.42 $3.01 Million - $3.87 Million	76,700 Added 166.74%	122,700 $53,000
Q2 2021 Aug 16, 2021	BUY	$35.91 - $40.68 $1.25 Million - $1.42 Million	34,900 Added 314.41%	46,000 $3,000
Q1 2021 May 17, 2021	SELL	$33.49 - $37.77 $150,705 - $169,965	-4,500 Reduced 28.85%	11,100 $10,000
Q4 2020 Feb 10, 2021	BUY	$33.47 - $42.56 $522,132 - $663,936	15,600 New	15,600 $3,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Bluefin Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bluefin Capital Management, LLC with notifications on news.